Millipore Sigma Vibrant Logo

410957 3-Isobutyl-1-methylxanthine - CAS 28822-58-4 - Calbiochem

View Products on Sigmaaldrich.com
410957
가격 및 재고 조회

개요

Replacement Information

주요 사양표

CAS #Empirical Formula
28822-58-4C₁₀H₁₄N₄O₂

가격 및 재고여부

카탈로그 번호 재고 정보패킹 포장 단위 가격(VAT 별도) 수량
410957-1GMCN
재고 정보 검색...
현재 재고 없음
현재 재고 없음
예상 출고 가능일 
단종품
제한된 수량 가능
재고여부 확인
    Remaining: will advise
      Remaining: will advise
      추천사항
      고객 서비스로 문의
      Contact Customer Service

      Plastic ampoule 1 gm
      가격 검색...
      가격을 검색할 수 없습니다
      Minimum Quantity needs to be mulitiple of
      Maximum Quantity is
      가격 문의 추가 정보
      ()이 할인됨
       
      가격 문의
      410957-250MGCN
      재고 정보 검색...
      현재 재고 없음
현재 재고 없음
      예상 출고 가능일 
      단종품
      제한된 수량 가능
      재고여부 확인
        Remaining: will advise
          Remaining: will advise
          추천사항
          고객 서비스로 문의
          Contact Customer Service

          Plastic ampoule 250 mg
          가격 검색...
          가격을 검색할 수 없습니다
          Minimum Quantity needs to be mulitiple of
          Maximum Quantity is
          가격 문의 추가 정보
          ()이 할인됨
           
          가격 문의
          Description
          OverviewA cell-permeable, non-specific inhibitor of cAMP and cGMP phosphodiesterases (IC50 = 2-50 µM). Also acts as an adenosine receptor antagonist. Reported to inhibit TNF-α expression in adipocyte precursor cells.
          Catalogue Number410957
          Brand Family Calbiochem®
          SynonymsIBMX
          References
          ReferencesHube, F., et al. 1999. Horm. Metab. Res. 31, 359.
          Morgan, A.J., et al. 1993. Biochem. Pharmacol. 45, 2373.
          Scamps, F., et al. 1993. Eur. J. Pharmacol. 244, 119.
          Turner, N.C., et al. 1993. Br. J. Pharmacol. 108, 876.
          Tamura, T., et al. 1991. J. Gen. Physiol. 98, 95.
          Beavo, J.A., and Reifsnyder, D.H. 1990. Trends Pharmacol. Sci. 11, 150.
          Russell, T.R. 1979. Proc. Natl. Acad. Sci. USA 76, 4451.
          Product Information
          CAS number28822-58-4
          ATP CompetitiveN
          FormWhite solid
          Hill FormulaC₁₀H₁₄N₄O₂
          Chemical formulaC₁₀H₁₄N₄O₂
          ReversibleN
          Structure formula ImageStructure formula Image
          Quality LevelMQ100
          Applications
          Application3-Isobutyl-1-methylxanthine, CAS 28822-58-4, is a cell-permeable, non-specific inhibitor of cAMP and cGMP phosphodiesterases (IC50 = 2-50 µM).
          Biological Information
          Primary TargetcAMP and cGMP phosphodiesterases
          Primary Target IC<sub>50</sub>2-50 µM against cAMP and cGMP phosphodiesterases
          Purity≥98% by HPLC
          Physicochemical Information
          Cell permeableY
          Dimensions
          Materials Information
          Toxicological Information
          Safety Information according to GHS
          RTECSZD8500000
          Safety Information
          Product Usage Statements
          Storage and Shipping Information
          Ship Code Ambient Temperature Only
          Toxicity Standard Handling
          Storage -20°C
          Do not freeze Ok to freeze
          Special InstructionsFollowing reconstitution in ethanol or methanol, refrigerate (4°C). Following reconstitution in DMSO, aliquot and freeze (-20°C). Ethanol/methanol and DMSO stock solutions are stable for up to 6 months at 4°C or -20°C, respectively.
          Packaging Information
          Transport Information
          Supplemental Information
          Specifications
          Global Trade Item Number
          카탈로그 번호 GTIN
          410957-1GMCN 04055977211139
          410957-250MGCN 04055977211146

          Documentation

          3-Isobutyl-1-methylxanthine - CAS 28822-58-4 - Calbiochem MSDS

          타이틀

          물질안전보건자료(MSDS) 

          3-Isobutyl-1-methylxanthine - CAS 28822-58-4 - Calbiochem Certificates of Analysis

          TitleLot Number
          410957

          References

          참고문헌 보기
          Hube, F., et al. 1999. Horm. Metab. Res. 31, 359.
          Morgan, A.J., et al. 1993. Biochem. Pharmacol. 45, 2373.
          Scamps, F., et al. 1993. Eur. J. Pharmacol. 244, 119.
          Turner, N.C., et al. 1993. Br. J. Pharmacol. 108, 876.
          Tamura, T., et al. 1991. J. Gen. Physiol. 98, 95.
          Beavo, J.A., and Reifsnyder, D.H. 1990. Trends Pharmacol. Sci. 11, 150.
          Russell, T.R. 1979. Proc. Natl. Acad. Sci. USA 76, 4451.

          Brochure

          Title
          Activators and Inhibitors of Adenylate Cyclase Technical Bulletin
          Data Sheet

          Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

          Revision12-July-2013 JSW
          SynonymsIBMX
          DescriptionA non-specific, cell-permeable inhibitor of cAMP and cGMP phosphodiesterases (IC50 = 2-50 µM). Also acts as an adenosine receptor antagonist. Reported to inhibit TNFα expression in adipocyte precursor cells.
          FormWhite solid
          CAS number28822-58-4
          RTECSZD8500000
          Chemical formulaC₁₀H₁₄N₄O₂
          Structure formulaStructure formula
          Purity≥98% by HPLC
          SolubilityDMSO (100 mM), Ethanol (10 mg/ml), or Methanol (50 mg/ml). Heating may be required to achieve complete solubilization.
          Storage -20°C
          Do Not Freeze Ok to freeze
          Special InstructionsFollowing reconstitution in ethanol or methanol, refrigerate (4°C). Following reconstitution in DMSO, aliquot and freeze (-20°C). Ethanol/methanol and DMSO stock solutions are stable for up to 6 months at 4°C or -20°C, respectively.
          Toxicity Standard Handling
          ReferencesHube, F., et al. 1999. Horm. Metab. Res. 31, 359.
          Morgan, A.J., et al. 1993. Biochem. Pharmacol. 45, 2373.
          Scamps, F., et al. 1993. Eur. J. Pharmacol. 244, 119.
          Turner, N.C., et al. 1993. Br. J. Pharmacol. 108, 876.
          Tamura, T., et al. 1991. J. Gen. Physiol. 98, 95.
          Beavo, J.A., and Reifsnyder, D.H. 1990. Trends Pharmacol. Sci. 11, 150.
          Russell, T.R. 1979. Proc. Natl. Acad. Sci. USA 76, 4451.